Last reviewed · How we verify
NCT06140940: OLIPHANT
Motor Imagery in Aphantasia
NA trial testing High-definition transcranial direct current (HD-tDCS), active condition in Aphasia in 40 participants. Currently enrolling.
1 January 2027
Quick facts
| Lead sponsor | Hôpital le Vinatier |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 40 |
| Start date | 28 March 2024 |
| Primary completion | 1 January 2027 |
| Estimated completion | 1 January 2028 |
| Sites | 1 location across France |
Drugs / interventions tested
- High-definition transcranial direct current (HD-tDCS), active condition
- High-definition transcranial direct current (HD-tDCS), sham condition
Conditions studied
- Aphasia — all drugs for Aphasia →
Sponsor
Hôpital le Vinatier — full company profile →
Who can join
18 and older, any sex, with Aphasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study aims to characterize and modulate motor imagery abilities in individuals with aphantasia. The investigators will characterize the neurophysiological and physiological underpinnings of mental imagery abilities in participants with aphantasia by investigating several indices of motor imagery abilities and comparing them to participants with typical mental imagery abilities. The investigators will investigate whether non-invasive brain stimulation applied to the primary motor cortex improves mental imagery abilities in participants with aphantasia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06140940
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-definition transcranial direct current (HD-tDCS), active condition
Trials testing the same drug.
- NCT06208176 — HD-tDCS for Hallucinations · NA · not yet recruiting
- NCT05936307 — Externalization and Stimulation · NA · unknown
Other recruiting trials for Aphasia
Currently open trials in the same condition.
- NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
- NCT07397923 — Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia · Phase 2 · recruiting
- NCT07281313 — Aphasia Physical EXercise Study: Randomized Trial · NA · recruiting
- NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
- NCT06974279 — Post-Stroke Aphasia TMS · NA · recruiting
Other Hôpital le Vinatier trials
Trials by the same sponsor.
- NCT07428200 — Characterization of the Neural Bases of Mental Imagery in Individuals With Borderline Personality Disorder: An EEG Study · NA · not yet recruiting
- NCT07384819 — Duration of Moment in Autism · NA · not yet recruiting
- NCT06284382 — Interaction Between Early Trauma and Odor-induced Dopamine Release · NA · not yet recruiting
- NCT07119671 — Peer-aid and Hope Box · NA · not yet recruiting
- NCT06869915 — Homelessness and Prevalence of Neurodevelopmental Disorders · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06140940 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital le Vinatier
- Last refreshed: 24 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06140940.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing